Electrosurgery Articles & Analysis

The University of Arizona has licensed the design for a next-generation needle biopsy instrument that utilizes electrosurgery and electrocautery to safely increase tissue sample volumes in minimally invasive biopsy procedures. The licensee is a startup company, Data Driven Diagnostics Sciences Inc., also known as D3Sciences, or D3S. The inventing team includes Dr. Michael Larson, resident ...

By Data Driven Diagnostic Sciences (D3Sciences)

BOSTON, MA, October 21, 2020 – DermBiont, Inc., a clinical stage precision dermatology company targeting skin diseases at their root cause has expanded its pipeline and therapeutic modalities with the acquisition of SeylanMED, Inc. “This strategic acquisition delivers multi-factorial value,” said Karl Beutner, MD, PhD, Co-founder, CEO, and CMO of DermBiont. “It expands ...

By DermBiont, Inc.

Presentations Highlight the PlasmaJet’s Atraumatic Approach to Surgery. Roswell, Georgia – April 15, 2015, – Plasma Surgical, creator of the PlasmaJet® Surgery System, an advanced energy-based medical device designed as a safe and effective alternative to traditional electrosurgery and other instruments, is pleased to recognize Professor Horace Roman’s presentations at ...

By Plasma Surgical, Inc.

FDA 510(k) clearance for removal of soft tissue by vaporization offers additional utility for surgeons ROSWELL, Ga. – May 1, 2013 – Plasma Surgical, creator of the PlasmaJet®, an advanced energy medical device designed as a safe and effective alternative to traditional electrosurgery instruments, announced today that it has received 510(k) clearance from the U.S. Food and Drug ...

By Plasma Surgical, Inc.

US Medical Innovations, LLC (USMI), a U.S. FDA-registered life-science and biomedical device company and the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) announced today that Jerome Canady MD, CEO will be presenting at the Baird Global Healthcare Conference on Tuesday, September 14th from 10:15 to 10:45 AM ET. Dr. Canady will present results ...

By US Medical Innovations, LLC

MENLO PARK, California, October 9, 2020 — Galaxy Medical, (Galaxy), a developer of Pulsed Electric Field (PEF) technology for the treatment of cardiac arrhythmias, today announced that the first patients were successfully treated with the proprietary CENTAURI™ System by Dr. Ante Ani in Split, Croatia as part of the ECLIPSE-AF study. This multicenter trial is designed to assess the ...

By Galaxy Medical

US Medical Innovations, LLC (USMI) and the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) announced today that the United States Patent and Trademark Office has issued a Notice of Allowance in connection with JCRI-ABTS’s US National Stage Application (Serial No. 17/284,762) entitled “SYSTEM FOR TREATMENT OF RESPIRATORY INFECTIONS AND ...

By US Medical Innovations, LLC

Connecticut-based medical device innovator Lumendi, LLC (http://www.lumendi.com) has announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the DiLumen Ik™ Endolumenal Interventional Knife, a sterile, single-use, disposable monopolar electrosurgical device for cutting, dissecting, and cauterizing tissue within the digestive tract during endoscopic procedures. ...

By Lumendi Ltd.

A large complex sigmoid polyp in a 62-year-old male patient was successfully removed in a 60-minute procedure without surgical intervention using DiLumen C2, a second-generation endoscopic dual balloon colon stabilization accessory that employs two 6mm working channels that accommodate several flexible therapeutic instruments designed to efficiently retract and dissect tissue. The endolumenal ...

By Lumendi Ltd.